Tronosjet Manufacturing Inc. receives funding from Government of Canada to develop testing swabs for COVID-19
Funding will be delivered through the National Research Council of Canada Industrial Research Assistance Program
September 3, 2020 – Ottawa, Ont. – National Research Council of Canada
Testing for COVID-19 is the only way to find and isolate those who have the virus to prevent its spread and future outbreaks.
Today, the National Research Council of Canada announced Tronosjet Manufacturing Inc. is receiving advisory services and up to $95,000 in research and development funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP).
Using additive manufacturing technologies, Tronosjet Manufacturing Inc. is developing 3D‑printed nasal testing swabs which will be used in testing kits to detect COVID‑19. If approved by Health Canada, the company is aiming to secure the materials and equipment to be able to produce 30,000 nasal testing swabs per day at their facilities in Charlottetown, Prince Edward Island.
“We are very pleased to announce the advisory services and funding for Tronosjet Manufacturing Inc. Their ability to leverage their expertise to respond to the global COVID‑19 pandemic demonstrates how Canadians’ innovative ideas can benefit the world.”
President, National Research Council of Canada
“The COVID‑19 pandemic is something that affects us all. With this funding we will be able to explore how to best use our facilities to respond to this urgent need for COVID‑19 testing swabs. We are hopeful our solution will provide Canadians with a reliable domestic source of nasal swabs for COVID‑19 to help life get a little more back to normal.”
CEO, Tronosjet Manufacturing Inc.
Tronosjet Manufacturing Inc. is headquartered in Summerside PEI with a manufacturing facility located in Charlottetown.
National Research Council of Canada
Report a problem or mistake on this page
- Date modified: